Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (41-50 of 438) with videos related to

Pageof 44
Sort By:
Journal of Medical Virology|February 1, 2018
Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysisLucio Boglione, Giuseppe Cariti, Valeria Ghisetti, et al.
Hospital Pharmacy|October 9, 2015
In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing MeropenemCristina Tomasello, Anna Leggieri, Roberta Cavalli, et al.
Infectious Medicine|March 7, 2024
HBsAg kinetics after 7 years of therapy with tenofovir disoproxil fumarate in a cohort of naïve patients affected by chronic hepatitis B with different genotypesLucio Boglione, Tommaso Lupia, Giacomo Stroffolini, et al.
Le Infezioni in Medicina|March 28, 2008
[Relapsing infection of cranial prosthesis sustained by Enterobacter cloacae and methicillin-resistant Staphylococcus aureus]Silvia Garazzino, Francesco Giuseppe De Rosa, Olivia Bargiacchi, et al.
Antiviral Research|November 7, 2016
Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferonLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.
The New Microbiologica|April 28, 2015
Re-defining tigecycline therapyFrancesco G De Rosa, Silvia Corcione, Giovanni Di Perri, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 29, 2021
The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIVAndrea Calcagno, Mattia Trunfio, Antonio D'Avolio, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 6, 2017
Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis CLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.
Antiviral Research|February 10, 2015
Treatment optimization of naïve HCV-1 patients using IL28B, RVR and fibrosis stageLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2002
Lactacidemia in asymptomatic HIV-infected subjects receiving nucleoside reverse-transcriptase inhibitorsMarta Boffito, Giorgio Marietti, Sabrina Audagnotto, et al.
Pageof 44

Showing results (41-50 of 438) with videos related to

Sort By:
Pageof 44
Journal of Medical Virology|February 1, 2018
Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysisLucio Boglione, Giuseppe Cariti, Valeria Ghisetti, et al.
Hospital Pharmacy|October 9, 2015
In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing MeropenemCristina Tomasello, Anna Leggieri, Roberta Cavalli, et al.
Infectious Medicine|March 7, 2024
HBsAg kinetics after 7 years of therapy with tenofovir disoproxil fumarate in a cohort of naïve patients affected by chronic hepatitis B with different genotypesLucio Boglione, Tommaso Lupia, Giacomo Stroffolini, et al.
Le Infezioni in Medicina|March 28, 2008
[Relapsing infection of cranial prosthesis sustained by Enterobacter cloacae and methicillin-resistant Staphylococcus aureus]Silvia Garazzino, Francesco Giuseppe De Rosa, Olivia Bargiacchi, et al.
Antiviral Research|November 7, 2016
Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferonLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.
The New Microbiologica|April 28, 2015
Re-defining tigecycline therapyFrancesco G De Rosa, Silvia Corcione, Giovanni Di Perri, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 29, 2021
The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIVAndrea Calcagno, Mattia Trunfio, Antonio D'Avolio, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 6, 2017
Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis CLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.
Antiviral Research|February 10, 2015
Treatment optimization of naïve HCV-1 patients using IL28B, RVR and fibrosis stageLucio Boglione, Jessica Cusato, Giuseppe Cariti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2002
Lactacidemia in asymptomatic HIV-infected subjects receiving nucleoside reverse-transcriptase inhibitorsMarta Boffito, Giorgio Marietti, Sabrina Audagnotto, et al.
Pageof 44